These findings provide insight into the therapeutic approach to modulating cadmium-induced male infertility, such as through the p38 MAPK inhibitor or in combination with the JNK activator and p-FAK Tyr397 and p-FAK Tyr576, respectively. The gene discussed is PTK2; the disease is male infertility.